Gemini Therapeutics, Inc. (NASDAQ:GMTX) Given Average Recommendation of “Buy” by Analysts

Retrieved on: 2022-05-21 20:34:24

Tags for this article:

Click the tags to see associated articles and topics

Gemini Therapeutics, Inc. (NASDAQ:GMTX) Given Average Recommendation of “Buy” by Analysts. View article details on hiswai:

Excerpt

Renaissance Technologies LLC bought a new stake in shares of Gemini Therapeutics in the 4th quarter valued at about $35,000.

Article found on: www.etfdailynews.com